NewsBenzingaMIRAファーマシューティカルズ、食餌誘発性肥満マウスモデルにおける肥満および代謝障害を対象としたSKNY-1のパイロット試験から初期概念実証結果を発表;SKNY-1経口投与により、ビークル投与対照群と比較して体重および脂肪量が統計学的に有意に減少したことを示す研究結果 MIRAファーマシューティカルズ、食餌誘発性肥満マウスモデルにおける肥満および代謝障害を対象としたSKNY-1のパイロット試験から初期概念実証結果を発表;SKNY-1経口投与により、ビークル投与対照群と比較して体重および脂肪量が統計学的に有意に減少したことを示す研究結果 Benzinga 2026.10.28 20:42 (GMT+0) Open on Benzinga Other news Salesforce Issues Security Advisory On Third-Party Optimizely Script Incident Affecting Certain Salesforce-Branded Sites; Optimizely Scripts Being Confirmed Disabled FBI Reissues Warning About AI-Powered Cyberattacks on Businesses as Crypto Bettors Dismiss AI Link to FAA Outage SpaceX, Meta and Nebius Stand to Benefit From Nvidia’s ‘Fastest Product Ramp’ Yet: Strategist Shay Boloor Explains Why Binance Plans to Expand into Five Asian Markets Next Year, Focusing on South and Southeast Asia Innate Pharma Reports IPH4502 Phase 1 Data Across 76 Patients: Maximum Tolerated Dose 3.6 Mg/Kg Q3W, Grade 3+ TEAEs In 43.4%, Stomatitis Only Dose-Limiting Toxicity Olema Reports Selective KAT6A Degraders Potently Inhibit Proliferation In Diverse ER+/HER2- Breast Cancer Models, Active In ESR1-Mutant And Wild-Type, Well-Tolerated
Salesforce Issues Security Advisory On Third-Party Optimizely Script Incident Affecting Certain Salesforce-Branded Sites; Optimizely Scripts Being Confirmed Disabled
FBI Reissues Warning About AI-Powered Cyberattacks on Businesses as Crypto Bettors Dismiss AI Link to FAA Outage
SpaceX, Meta and Nebius Stand to Benefit From Nvidia’s ‘Fastest Product Ramp’ Yet: Strategist Shay Boloor Explains Why
Innate Pharma Reports IPH4502 Phase 1 Data Across 76 Patients: Maximum Tolerated Dose 3.6 Mg/Kg Q3W, Grade 3+ TEAEs In 43.4%, Stomatitis Only Dose-Limiting Toxicity
Olema Reports Selective KAT6A Degraders Potently Inhibit Proliferation In Diverse ER+/HER2- Breast Cancer Models, Active In ESR1-Mutant And Wild-Type, Well-Tolerated